Insider trade

Officer sold ~$284K of VTRS shares in the open market

Traded Mar 23, 2026 · Filed Mar 24, 2026

ViatrisVTRS

~$284K
Reported value · 21K sh @ $13.2805: 366K
Holds after · shares reported: +31.4%
stock since the trade · S&P 500 +16.6%, $13.29 → $17.46 on Oct 1

Why it stands out

Viatris's See Remarks sold $284K of Viatris shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 23, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 24, 2026

Officer$100K–$500K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$283,539

Shares × reported transaction price

Timing vs results

25 days after results of Feb 26, 2026, 45 days before results of May 7, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $13.29 on Mar 23, 2026, 83% above its 52-week low and 18% below its high, after a 9% drop over the previous 30 trading days

52-week range $7.26 (Apr 10, 2025) to $16.13 (Feb 11, 2026), 68% of the way up, from 251 adjusted closes. 30 trading days earlier: $14.58 on Feb 6, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

FDA decision near the trade

FDA approved Aprepitant on Mar 5, 2026, 18 days before this trade.

Generic drug approved. Active ingredient: Aprepitant. From openFDA. Dates only; no link between the two is implied

After it was reported

After	Stock	S&P 500	Difference
7 days	+1.0%	-0.2%	+1.2%
30 days	+8.1%	+8.7%	-0.6%
90 days	+16.7%	+11.7%	+5.0%
180 days	+26.7%	+17.8%	+8.9%

Past results only. Not a forecast.

Source receipt

Record ID: 0001140361-26-010933
Filed / recorded: Mar 24, 2026, 10:04 PM UTC
Added to OQRO: Oct 2, 2026, 12:29 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: Viatris Inc
Issuer CIK: 1792044
Ticker: VTRS
Reporting person: Paul Campbell
Relationship: Officer
Officer title: See Remarks
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Mar 23, 2026
Transaction code: S
Shares / units: 21,350
Price per share: $13.2805
Acquired / disposed: Disposed (D)
Shares owned after: 366,288
Ownership form: Direct
Amendment: No

Footnotes from the filing

Represents the weighted average price of the reporting person's disposition of 21,350 shares of common stock in transactions ranging from $13.205 to $13.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.